6533b832fe1ef96bd129a3b8

RESEARCH PRODUCT

Third Case of Visceral Leishmaniasis in COVID-19: Mini Review Article.

Claudia ColombaCristoforo GuccioneRaffaella RubinoMichela ScalisiAnna CondemiSara BagarelloSalvatore GiordanoAntonio Cascio

subject

Microbiology (medical)visceral leishmaniasis.Infectious DiseasesGeneral Immunology and MicrobiologyCOVID-19Immunology and AllergyMolecular Biologycoinfection

description

Background: In the currently ongoing coronavirus pandemic, coinfections with unrelated life-threatening febrile conditions may pose a particular challenge to clinicians. Leishmaniasis is a zoonosis that may present general symptoms, including fever, malaise, and arthralgia, rendering it indistinguishable from COVID-19. Methods: In this paper, we aim to draw attention to this issue and analyze the clinical characteristics of the coinfection SARS-CoV-2/Leishmania through a systematic review of the literature. We were motivated by the observation of the first case of visceral leishmaniasis and COVID-19 in a paediatric patient. Conclusion: Our case is a reminder for healthcare providers to consider the diagnosis of visceral leishmaniasis in patients presenting with febrile syndrome in endemic regions during the COVID-19 pandemic.

yearjournalcountryeditionlanguage
2022-08-14Pathogens (Basel, Switzerland)
10.3390/pathogens11080913https://pubmed.ncbi.nlm.nih.gov/36015034